cimetidine has been researched along with Adenohypophyseal Diseases in 1 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García Centenera, JA | 1 |
Requejo, F | 1 |
Alba, JP | 1 |
Herrán, M | 1 |
Lucero, JL | 1 |
Vilchez, JM | 1 |
Hervás, F | 1 |
1 trial available for cimetidine and Adenohypophyseal Diseases
Article | Year |
---|---|
[H2-receptors and prolactin secretion. Effects of acute and chronic administration of cimetidine on subjects with normal and high levels of prolactin (author's transl)].
Topics: Adult; Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Guanidines; Humans; I | 1980 |